SlideChat: A Large Vision-Language Assistant for Whole-Slide Pathology Image Understanding

Despite the progress made by multimodal large language models (MLLMs) in computational pathology, they remain limited by a predominant focus on patch-level analysis, missing essential contextual information at the whole-slide level. The lack of large-scale instruction datasets and the gigapixel scale of whole slide images (WSIs) pose significant developmental challenges. In this paper, we present SlideChat, the first vision-language assistant capable of understanding gigapixel whole-slide images, exhibiting excellent multimodal conversational capability and response complex instruction across diverse pathology scenarios. To support its development, we created SlideInstruction, the largest instruction-following dataset for WSIs consisting of 4.2K WSI captions and 176K VQA pairs with multiple categories. Furthermore, we propose SlideBench, a multimodal benchmark that incorporates captioning and VQA tasks to assess SlideChat's capabilities in varied clinical settings such as microscopy, diagnosis. Compared to both general and specialized MLLMs, SlideChat exhibits exceptional capabilities achieving state-of-the-art performance on 18 of 22 tasks. For example, it achieved an overall accuracy of 81.17% on SlideBench-VQA (TCGA), and 54.15% on SlideBench-VQA (BCNB). We will fully release SlideChat, SlideInstruction and SlideBench as open-source resources to facilitate research and development in computational pathology.

GMAI-MMBench: A Comprehensive Multimodal Evaluation Benchmark Towards General Medical AI

Large Vision-Language Models (LVLMs) are capable of handling diverse data types such as imaging, text, and physiological signals, and can be applied in various fields. In the medical field, LVLMs have a high potential to offer substantial assistance for diagnosis and treatment. Before that, it is crucial to develop benchmarks to evaluate LVLMs' effectiveness in various medical applications. Current benchmarks are often built upon specific academic literature, mainly focusing on a single domain, and lacking varying perceptual granularities. Thus, they face specific challenges, including limited clinical relevance, incomplete evaluations, and insufficient guidance for interactive LVLMs. To address these limitations, we developed the GMAI-MMBench, the most comprehensive general medical AI benchmark with well-categorized data structure and multi-perceptual granularity to date. It is constructed from 285 datasets across 39 medical image modalities, 18 clinical-related tasks, 18 departments, and 4 perceptual granularities in a Visual Question Answering (VQA) format. Additionally, we implemented a lexical tree structure that allows users to customize evaluation tasks, accommodating various assessment needs and substantially supporting medical AI research and applications. We evaluated 50 LVLMs, and the results show that even the advanced GPT-4o only achieves an accuracy of 52\%, indicating significant room for improvement. Moreover, we identified five key insufficiencies in current cutting-edge LVLMs that need to be addressed to advance the development of better medical applications. We believe that GMAI-MMBench will stimulate the community to build the next generation of LVLMs toward GMAI.

Morphological Profiling for Drug Discovery in the Era of Deep Learning

Morphological profiling is a valuable tool in phenotypic drug discovery. The advent of high-throughput automated imaging has enabled the capturing of a wide range of morphological features of cells or organisms in response to perturbations at the single-cell resolution. Concurrently, significant advances in machine learning and deep learning, especially in computer vision, have led to substantial improvements in analyzing large-scale high-content images at high-throughput. These efforts have facilitated understanding of compound mechanism-of-action (MOA), drug repurposing, characterization of cell morphodynamics under perturbation, and ultimately contributing to the development of novel therapeutics. In this review, we provide a comprehensive overview of the recent advances in the field of morphological profiling. We summarize the image profiling analysis workflow, survey a broad spectrum of analysis strategies encompassing feature engineering- and deep learning-based approaches, and introduce publicly available benchmark datasets. We place a particular emphasis on the application of deep learning in this pipeline, covering cell segmentation, image representation learning, and multimodal learning. Additionally, we illuminate the application of morphological profiling in phenotypic drug discovery and highlight potential challenges and opportunities in this field.

Identifying acute illness phenotypes via deep temporal interpolation and clustering network on physiologic signatures

Initial hours of hospital admission impact clinical trajectory, but early clinical decisions often suffer due to data paucity. With clustering analysis for vital signs within six hours of admission, patient phenotypes with distinct pathophysiological signatures and outcomes may support early clinical decisions. We created a single-center, longitudinal EHR dataset for 75,762 adults admitted to a tertiary care center for 6+ hours. We proposed a deep temporal interpolation and clustering network to extract latent representations from sparse, irregularly sampled vital sign data and derived distinct patient phenotypes in a training cohort (n=41,502). Model and hyper-parameters were chosen based on a validation cohort (n=17,415). Test cohort (n=16,845) was used to analyze reproducibility and correlation with biomarkers. The training, validation, and testing cohorts had similar distributions of age (54-55 yrs), sex (55% female), race, comorbidities, and illness severity. Four clusters were identified. Phenotype A (18%) had most comorbid disease with higher rate of prolonged respiratory insufficiency, acute kidney injury, sepsis, and three-year mortality. Phenotypes B (33%) and C (31%) had diffuse patterns of mild organ dysfunction. Phenotype B had favorable short-term outcomes but second-highest three-year mortality. Phenotype C had favorable clinical outcomes. Phenotype D (17%) had early/persistent hypotension, high rate of early surgery, and substantial biomarker rate of inflammation but second-lowest three-year mortality. After comparing phenotypes' SOFA scores, clustering results did not simply repeat other acuity assessments. In a heterogeneous cohort, four phenotypes with distinct categories of disease and outcomes were identified by a deep temporal interpolation and clustering network. This tool may impact triage decisions and clinical decision-support under time constraints.

Tableaux for the Logic of Strategically Knowing How

The logic of goal-directed knowing-how extends the standard epistemic logic with an operator of knowing-how. The knowing-how operator is interpreted as that there exists a strategy such that the agent knows that the strategy can make sure that p. This paper presents a tableau procedure for the multi-agent version of the logic of strategically knowing-how and shows the soundness and completeness of this tableau procedure. This paper also shows that the satisfiability problem of the logic can be decided in PSPACE.

A Bioinspired Synthetic Nervous System Controller for Pick-and-Place Manipulation

The Synthetic Nervous System (SNS) is a biologically inspired neural network (NN). Due to its capability of capturing complex mechanisms underlying neural computation, an SNS model is a candidate for building compact and interpretable NN controllers for robots. Previous work on SNSs has focused on applying the model to the control of legged robots and the design of functional subnetworks (FSNs) to realize dynamical systems. However, the FSN approach has previously relied on the analytical solution of the governing equations, which is difficult for designing more complex NN controllers. Incorporating plasticity into SNSs and using learning algorithms to tune the parameters offers a promising solution for systematic design in this situation. In this paper, we theoretically analyze the computational advantages of SNSs compared with other classical artificial neural networks. We then use learning algorithms to develop compact subnetworks for implementing addition, subtraction, division, and multiplication. We also combine the learning-based methodology with a bioinspired architecture to design an interpretable SNS for the pick-and-place control of a simulated gantry system. Finally, we show that the SNS controller is successfully transferred to a real-world robotic platform without further tuning of the parameters, verifying the effectiveness of our approach.

BatmanNet: Bi-branch Masked Graph Transformer Autoencoder for Molecular Representation

Although substantial efforts have been made using graph neural networks (GNNs) for AI-driven drug discovery (AIDD), effective molecular representation learning remains an open challenge, especially in the case of insufficient labeled molecules. Recent studies suggest that big GNN models pre-trained by self-supervised learning on unlabeled datasets enable better transfer performance in downstream molecular property prediction tasks. However, they often require large-scale datasets and considerable computational resources, which is time-consuming, computationally expensive, and environmentally unfriendly. To alleviate these limitations, we propose a novel pre-training model for molecular representation learning, Bi-branch Masked Graph Transformer Autoencoder (BatmanNet). BatmanNet features two tailored and complementary graph autoencoders to reconstruct the missing nodes and edges from a masked molecular graph. To our surprise, BatmanNet discovered that the highly masked proportion (60%) of the atoms and bonds achieved the best performance. We further propose an asymmetric graph-based encoder-decoder architecture for either nodes and edges, where a transformer-based encoder only takes the visible subset of nodes or edges, and a lightweight decoder reconstructs the original molecule from the latent representation and mask tokens. With this simple yet effective asymmetrical design, our BatmanNet can learn efficiently even from a much smaller-scale unlabeled molecular dataset to capture the underlying structural and semantic information, overcoming a major limitation of current deep neural networks for molecular representation learning. For instance, using only 250K unlabelled molecules as pre-training data, our BatmanNet with 2.575M parameters achieves a 0.5% improvement on the average AUC compared with the current state-of-the-art method with 100M parameters pre-trained on 11M molecules.

Knowing How to Plan

Various planning-based know-how logics have been studied in the recent literature. In this paper, we use such a logic to do know-how-based planning via model checking. In particular, we can handle the higher-order epistemic planning involving know-how formulas as the goal, e.g., find a plan to make sure p such that the adversary does not know how to make p false in the future. We give a PTIME algorithm for the model checking problem over finite epistemic transition systems and axiomatize the logic under the assumption of perfect recall.

Joint Dimensionality Reduction for Separable Embedding Estimation

Low-dimensional embeddings for data from disparate sources play critical roles in multi-modal machine learning, multimedia information retrieval, and bioinformatics. In this paper, we propose a supervised dimensionality reduction method that learns linear embeddings jointly for two feature vectors representing data of different modalities or data from distinct types of entities. We also propose an efficient feature selection method that complements, and can be applied prior to, our joint dimensionality reduction method. Assuming that there exist true linear embeddings for these features, our analysis of the error in the learned linear embeddings provides theoretical guarantees that the dimensionality reduction method accurately estimates the true embeddings when certain technical conditions are satisfied and the number of samples is sufficiently large. The derived sample complexity results are echoed by numerical experiments. We apply the proposed dimensionality reduction method to gene-disease association, and predict unknown associations using kernel regression on the dimension-reduced feature vectors. Our approach compares favorably against other dimensionality reduction methods, and against a state-of-the-art method of bilinear regression for predicting gene-disease associations.

PRI-VAE: Principle-of-Relevant-Information Variational Autoencoders

Although substantial efforts have been made to learn disentangled representations under the variational autoencoder (VAE) framework, the fundamental properties to the dynamics of learning of most VAE models still remain unknown and under-investigated. In this work, we first propose a novel learning objective, termed the principle-of-relevant-information variational autoencoder (PRI-VAE), to learn disentangled representations. We then present an information-theoretic perspective to analyze existing VAE models by inspecting the evolution of some critical information-theoretic quantities across training epochs. Our observations unveil some fundamental properties associated with VAEs. Empirical results also demonstrate the effectiveness of PRI-VAE on four benchmark data sets.